Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Role of Sarcopenia Risk in Predicting Covid-19 Severity and Length of Hospital Stay in Older Adults: A Prospective Cohort Study Publisher Pubmed



Ahmadiani ES1 ; Ariyanfar S1, 2 ; Soroush M3 ; Razeghi Jahromi S1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Headache Department, Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Nikan Education and Research Center, Tehran, Iran

Source: British Journal of Nutrition Published:2023


Abstract

Sarcopenia is more common in the elderly and causes adverse outcomes with increased morbidity and mortality. This prospective cohort study assessed the association of sarcopenia risk with the severity of COVID-19 at the time of admission and during hospitalisation and the length of hospital stay. Two hundred patients (aged ≥ 60 years) who were hospitalised for COVID-19 were enrolled using consecutive sampling between 29 December 2020 and 20 May 2021. The sarcopenia score of the patients was assessed using the Strength, Assistance in walking, Rising from a chair, Climbing stairs, and Falls questionnaire. The severity of COVID-19 was determined using the modified National Early Warning Score (m-NEWS) system for 2019 n-CoV-infected patients at admission (T1), day three (T2) and at discharge (T3). Data were analysed using SPSS, version 22 and STATA, version 14. Of the 165 patients included, thirty four (20·6 %) were at risk of sarcopenia. The length of hospital stay was slightly longer in patients with sarcopenia risk, but the difference was not significant (P = 0·600). The adjusted OR of respiratory rate (RR) > 20 /min at T1 for the sarcopenia risk group was 6·7-times higher than that for the non-sarcopenic group (P = 0·002). According to generalised estimating equations, after adjusting for confounding factors, the m-NEWS score was 5·6 units higher in patients at risk of sarcopenia (P < 0·001). Sarcopenia risk could exacerbate COVID-19 severity and increase RR at admission, as well as the need for oxygen therapy at discharge. © The Author(s), 2022. Published by Cambridge University Press on behalf of The Nutrition Society.
Related Docs
1. Prevalence and Impact of Probable Sarcopenia in Community-Dwelling Older Adults in Pakistan, Ageing International (2025)
2. Relationship Between Sarcopenia and Electrocardiographic Abnormalities in Older People: The Bushehr Elderly Health Program, Frontiers in Medicine (2021)
3. The Impact of Osteosarcopenia and Its Parameters on Mortality of Covid-19 In-Hospitalized Older Patients: The Findings of Beh (Bushehr Elderly Health) Program, Journal of Diabetes and Metabolic Disorders (2024)
4. The Efficacy of Sarcomeal® Oral Supplementation Plus Vitamin D3 on Muscle Parameters, Metabolic Factors, and Quality of Life in Diabetic Sarcopenia: A Randomized Controlled Clinical Trial, Aging Clinical and Experimental Research (2025)
5. The Effect of Sarcomeal® Oral Supplementation Plus Vitamin D3 on Muscle Parameters and Metabolic Factors in Diabetic Sarcopenia Patients: Study Protocol of a Randomized Controlled Clinical Trial, Trials (2024)
6. Association Between Dietary Intake of Branched-Chain Amino Acids and Sarcopenia and Its Components: A Cross-Sectional Study, Scientific Reports (2022)
7. Development of a Simple and Practical Screening Tool for Detection of Sarcopenia in Older People: The Bushehr Elderly Health Program, Frontiers in Medicine (2021)
Experts (# of related papers)
View all Related Experts
Ramin Heshmat (6)
Gita Shafiee (5)